1887

Abstract

In this study the minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of 5-hydroxytryptamine (5 HT, serotonin) against clinical isolates of ( = 11), ( = 9), ( = 10) and s (ATCC 22019) using a broth microdilution test were investigated. In addition, it was examined whether delayed regrowth as a post-antifungal effect results following short exposure to 5 HT. 5 HT showed antifungal activity towards all isolates of spp. The isolates yielded comparable MIC and MFC values of 5 HT in the range 0.91–7.34 mM and 1.83–14.68 mM, respectively. A lag in regrowth was dependent on the concentration tested. Treatment for 3 h at concentrations of 5 HT below and equipotent to the MFC resulted in a delayed regrowth of 8–12 h for isolates of spp. In conclusion, these studies clearly demonstrate antifungal effects of 5 HT. Identifying the mode of action could be of great help in developing and researching new antifungal drugs.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.04987-0
2003-02-01
2020-04-08
Loading full text...

Full text loading...

/deliver/fulltext/jmm/52/2/169.html?itemId=/content/journal/jmm/10.1099/jmm.0.04987-0&mimeType=html&fmt=ahah

References

  1. Brown M. W. 1975; In vitro antibacterial activity of drugs against human intestinal anaerobic bacteria. J Pharm Sci 64:700–702 [CrossRef]
    [Google Scholar]
  2. Cederlund H, Mardh P. A. 1993; Antibacterial activities of non-antibiotic drugs. J Antimicrob Chemother 32:355–365
    [Google Scholar]
  3. Christin L, Wysong T, Meshulam R, Hastey E, Simons E. R, Diamond R. 1998; Human platelets damage Aspergillus fumigatus hyphae and may supplement killing neutrophils. Infect Immun 66:1181–1189
    [Google Scholar]
  4. Coutaux A. F, Mooney J. J, Wirth D. F. 1994; Neuronal monoamine reuptake inhibitors enhance in vitro susceptibility to chloroquine in resistant Plasmodium falciparum . Antimicrob Agents Chemother 38:1419–1421 [CrossRef]
    [Google Scholar]
  5. Dimmock P. W, Wyatt K. M, Jones P. W, O'Brien P. M. 2000; Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systemic review. Lancet 356:1131–1136
    [Google Scholar]
  6. Harenbe J, Huhle G, Giese C, Wang L, Feuring M, Song X, Hoffman U. 2000; Determination of serotonin release from platelets by enzyme immunoassay in the diagnosis of heparin-induced thrombocytopenia. Br J Haematol 109:182–186
    [Google Scholar]
  7. Helmeste D, Tang S. W, Vu R. 1998; Inhibition of platelet serotonin uptake by cytochrome P 450 inhibitors miconazole and econazole. Life Sci 62:2203–2208
    [Google Scholar]
  8. Kumar A, Kumar M, Deepika K, Fernandez J, Eisdorfer C. 1990; A modified HPLC technique for simultaneous measurement of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in cerebrospinal fluid, platelet and plasma. Life Sci 47:1751–1759
    [Google Scholar]
  9. Larsson M, Hagberg L, Norkans G, Forsman A. 1989; Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection. J Neurosci Res 23:441–446
    [Google Scholar]
  10. Lass-Flörl C, Dierich M, Fuchs D, Semenitz E, Ledochowski M. 2001a; Antifungal activity against Candida species of the selective serotonin reuptake inhibitor sertraline. . Clin Infect Dis 33:e135–e136
    [Google Scholar]
  11. Lass-Flörl C, Dierich M, Fuchs D, Semenitz E, Jenewein I, Ledochowski M. 2001b; Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro. J Antimicrob Chemother 48:775–779
    [Google Scholar]
  12. Lass-Flörl C, Wiedauer B, Mayr A, Kirchmair M, Jenewein I, Ledochowski M, Dierich M. P. 2002; Antifungal properties of 5-HT (serotonin) against Aspergillus spp. in vitro. Int J Med Microbiol 291:655–657
    [Google Scholar]
  13. Munoz-Bellido J. L, Munoz-Criado S, Garcia-Rodriguez J. A. 1996; In vitro activity of psychiatric drugs against Corynebacterium urealyticum ( Corynebacterium group D2). J Antimicrob Chemother 37:1005–1009
    [Google Scholar]
  14. Munoz-Bellido J. L, Munoz-Criado S, Garcia-Rodriguez J. A. 2000; Antimicrobial activity of psychotropic drugs selective serotonin reuptake inhibitors. Int J Antimicrob Agents 14:177–180
    [Google Scholar]
  15. Nagl M, Hengster P, Semenitz E, Waldemar G. 1999; The postantibiotic effect of N -chlorotaurine on Staphylococcus aureus . Application in the mouse peritonitis model. J Antimicrob Chemother 43:804–809
    [Google Scholar]
  16. National Committee for Clinical Laboratory Standards; 1997; Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard MA 27 Villa Nova, PA: NCCLS;
    [Google Scholar]
  17. Rendu F, Breton-Gorius J, Lebret M, Klebanoff C, Buriot D, Griscelli C, Levy-Toledano S, Caen J. P. 1983; Evidence that abnormal platelet functions in human Chediak–Higashi syndrome are the result of a lack of dense bodies. Am J Pathol 111:307–314
    [Google Scholar]
  18. Schloss P, Williams D. 1998; The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 12:115–121
    [Google Scholar]
  19. Schuff-Werner P, Splettstoesser W. 1999; Antioxidative properties of serotonin and the bactericidal function of polymorphonuclear phagocytes. In Tryptophan, Serotonin, and MelatoninBasic Aspects and Applications pp 321–325 Edited by Huether G., Kochen T., Simat T. J., Steinhart H. New York: Kluwer/Plenum;
    [Google Scholar]
  20. Tu J, Zellweger H. 1965; Blood-serotonin deficiency in Down's syndrome. Lancet ii:715–716
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.04987-0
Loading
/content/journal/jmm/10.1099/jmm.0.04987-0
Loading

Data & Media loading...

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error